Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Search Results

Now showing 1 - 10 of 16
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SINUSITIS TREATMENT IN PREGNANCY- PERSONALISED AND INTEGRATED MEDICINE
    (Македонско лекарско друштво = Macedonian medical association, 2024-12)
    ;
    ;
    ;
    Sofija Nikolovska
    ;
    Budima Pejkovska Shahpaska
    Introduction. Sinusitis in pregnant patients is a disorder with incidence of around 3-4% worldwide, dependent from the impaired immune system. Long lasting symptoms are sometimes accompanied with nasal polyposis that is aggravated due to pregnancy hormones. The chronic condition has its relapses, with inflammatory or noninflamatory causes. Systematic analysis, diagnostic evaluations, treatment options must be personalized and dependent of the pregnancy trimester for a favorable pregnancy outcome with the help of integrated medicine. Methods. We present a pregnant patient in the second trimester of her third pregnancy. The symptoms that occurred in the 17.5 week of gestational age included headache, high body temperature, fatigue, muscle cramps, loss of appetite, nasal congestion and discharge. After clinical examinations of microbiological samples, nasal endoscopy, mechanical vacuum suction, chronic sinusitis aggravated by nasal polyposis with propagation from maxillary sinus was diagnosed. The treatment according to antibiogram and FDA approval for the trimester included local topic treatment with diluted cephalosporins, corticosteroids (fluticasone propionate),inhalations, antibiotics, probiotics and vitamins per os. Results and Discussion. Improvement of the subjective and objective symptomatology of the patient occurred after 5 weeks of treatment. Relapse occurred in the third trimester and two months postpartum. Immunopathohistologically, there is an antagonism of IgE, of interleukin IL-4, IL-5 and IL-13. The increase of IL-17 is proven for frequent exacerbations. Long lasting symptoms are sometimes accompanied with nasal polyposis that is aggravated due to pregnancy hormones. Conclusion. The immune system in pregnancy changes, with exaggerated inflammatory reaction inadequate to recover from sinusitis for a shorter period of time. Therefore, detailed examination and adequate therapy is obligatory as soon as the diagnosis is settled. All corticosteroids are not allowed in the second trimester due to proven unfavorable outcome for the fetus. Mechanical treatments and topic antibiotics were main therapeutic solution. Modern medicine aims to combine genetics and detection of the phenotype for chronic type of inflammation and the type of the immune response in order to stratify patients for appropriate treatment.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Short‐ and long‐term outcome and predictors in an international cohort of patients with neuro‐COVID‐19
    (Wiley, 2022-03-07)
    Beghi, Ettore
    ;
    Helbok, Raimund
    ;
    Ozturk, Serefnur
    ;
    Karadas, Omer
    ;
    Lisnic, Vitalie
    Background and purpose: Despite the increasing number of reports on the spectrum of neurological manifestations of COVID-19 (neuro-COVID), few studies have assessed short- and long-term outcome of the disease. Methods: This is a cohort study enrolling adult patients with neuro-COVID seen in neurological consultation. Data were collected prospectively or retrospectively in the European Academy of Neurology NEuro-covid ReGistrY ((ENERGY). The outcome at discharge was measured using the modified Rankin Scale and defined as 'stable/improved' if the modified Rankin Scale score was equal to or lower than the pre-morbid score, 'worse' if the score was higher than the pre-morbid score. Status at 6 months was also recorded. Demographic and clinical variables were assessed as predictors of outcome at discharge and 6 months. Results: From July 2020 to March 2021, 971 patients from 19 countries were included. 810 (83.4%) were hospitalized. 432 (53.3%) were discharged with worse functional status. Older age, stupor/coma, stroke and intensive care unit (ICU) admission were predictors of worse outcome at discharge. 132 (16.3%) died in hospital. Older age, cancer, cardiovascular complications, refractory shock, stupor/coma and ICU admission were associated with death. 262 were followed for 6 months. Acute stroke or ataxia, ICU admission and degree of functional impairment at discharge were predictors of worse outcome. 65/221 hospitalized patients (29.4%) and 10/32 non-hospitalized patients (24.4%) experienced persisting neurological symptoms/signs. 10/262 patients (3.8%) developed new neurological complaints during the 6 months of follow-up. Conclusions: Neuro-COVID is a severe disease associated with worse functional status at discharge, particularly in older subjects and those with comorbidities and acute complications of infection.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Pregnancy with fetal brain tumor
    (Македонско лекарско друштво = Macedonian medical association, 2024-04-25)
    ;
    ;
    ;
    Josheva, Jasminka
    Fetal intracranial tumors are exceptionally rare, occurring at an overall incidence of 0.34 per one thousand live births. As per the 2016 classification of central nervous system tumors, primitive neuroectodermal tumors (PNETs) are categorized as highly malignant embryonal tumors in WHO Group IV. This case involves a 29-year-old in her third pregnancy, with two previous uneventful term deliveries. At 27+3 gestational weeks, she sought care at the University clinic due to fetal hydrocephalus. An ultrasound at 28 gestational weeks revealed a heterogenous, tumor-like mass measuring 70x66mm in the right brain hemisphere. The fetal head exhibited a whole dilated right ventricle (26mm posterior horn dimension) with a leftward shift of the cerebral falx. Subsequent fetal MRI demonstrated a partly solid, partly cystic tumor with a heterogenous appearance in T2 pulse sequence, extending in a frontoparietal direction. The differential diagnosis included glioblastoma. Following comprehensive scans, the parents were informed of the potential outcomes. The newborn, unfortunately, did not survive, weighing 1700g and measuring 42 centimeters. Pathological evaluation identified a primitive neuroectodermal tumor in the right parietal lobe, accompanied by internal hydrocephalus and cerebral encephalomalacia. Microscopic examination showcased Homer-Wright rosette formations, consisting of moderately differentiated round to oval cells with eosinophilic to amphophilic cytoplasm and hyperchromatic nuclei surrounding a central core of neurofibrillary material. Immune histochemical staining confirmed the tumor's profile, including Vimentin(+), S100(+), GFAP(+), Actin(-/+), Desmin(-), CD99(-), EMA(-), CKWS(-), Chromogranin(-), NSE(+), WT1(+), and Synaptophysin positivity in single cells with dendrites. The proliferative index stood at 2-3%. In summary, this rare case emphasizes the challenges of antenatal PNET diagnosis, with only 18% identified before or at delivery among tumors presenting in the first year of life.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    VACCINE BREAKTHROUGH INFECTIONS IN COVID-19 PATIENTS - SINGLE CENTER STUDY IN THE REPUBLIC OF NORTH MACEDONIA
    (Македонско лекарско друштво = Macedonian medical association/De Gruyter, 2022)
    ;
    ;
    Matevska, Sofija
    ;
    Our study evaluates vaccine breakthrough infections in Coronavirus Disease 2019 (COVID-19) patients who presented for medical examination at a tertiary care hospital in Skopje, Republic of North Macedonia. We retrospectively evaluated medical files of 249 completely vaccinated patients who presented at the hospital since June 2021 till October 2021, with a clinical picture of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. The average time from complete vaccination to symptom onset was 79.8±41.8 days. Out of 249 patients, 158(63.45%) were treated as outpatients, and 91(36.55%) were hospitalized. From the hospitalized patients, 61(67.03%) were discharged and 30(32.97) died. Breakthrough infections occurred in the Sinopharm vaccine group in 45.78%, Sinovac in 20.08%, Pfizer in 14.86%, AstraZeneca in 10.84% and Sputnik in 7.23%. The highest mortality was found in patients vaccinated with mRNA1273 vaccine, followed by inactivated virus containing vaccine and with non replicating viral vector vaccine, while the lowest mortality was found in those vaccinated with either BNT162b2 vaccine or human adenovirus vector-based COVID-19 vaccine. Male gender (p=0.006), age over 65 years (p=0.002) and presence of comorbidities (p=0.006) were major contributing factors for a poor outcome in vaccinated hospitalized patients with COVID-19. Due to the uneven distribution of the samples in our patient cohort it would be misleading to look at breakthrough cases, disease severity and outcome by vaccine brand due to different representation of vaccine brands. Breakthrough infection, hospitalization, and death from COVID -19 could differ across different vaccination profiles.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Assosiation of COVID-19 Infection and Acute Mesenteric Ischemia
    (The First Faculty of Medicine of Charles University - Karolinum press, 2023-12)
    ;
    Lazarova, Irena
    ;
    Popchanovski, Bojan
    ;
    Kostovska, Irena
    COVID-19 is an infectious disease that is considered to be a thrombo-inflammatory disorder. The study was aimed to determine the prevalence of COVID-19 in patients with acute mesenteric ischemia (AMI) and the outcomes of surgical treatment in relation to COVID-19. A total of 140 patients were included in this multicentric study divided into two groups: the test group (n=65) consisted of cases of AMI detected during the COVID-19 pandemic and the control group (n=65) consisted of cases of AMI detected before the pandemic. Test group patients were classified as COVID-positive (COVID+), or COVID-negative (COVID–) if they tested positive, respectively negative test for COVID-19 on admission. Primary outcomes were: prevalence of COVID-19 infection among test group patients, association between COVID-19 infection and inoperability, and between COVID-19 and treatment outcome. Secondary outcomes were association between each blood parameter and inoperability and treatment outcome. There were no statistically significant differences between inoperability and COVID-19 positivity on admission, overall mortality between the control group and the test group and overall mortality between COVID+ and COVID– patients, as well as among those patients that have been surgically treated (p>0.05). There were statistically significant differences between serum amylase levels (p=0.034), and serum LDH levels (p=0.0382) and inoperability, between serum LDH levels and postoperative mortality (p=0.0151), and overall mortality (p=0.00163). High level of LDH and serum pancreatic amylase are associated with a higher rate of inoperability and a higher postoperative and overall mortality rate. COVID-19 does not seem to independently influence the treatment outcome of AMI.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Association of CURB-65 (Confusion, Urea, Respiratory Rate, Blood Pressure) with Mortality of Patients with Severe Community-Acquired Pneumonia
    (Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 2009)
    ;
    ;
    ;
    Background. Severe community-acquired pneumonia (sCAP) is serious, life-thretening condition, with high mortality rate. Scoring systems for disease severity are used for predicting mortality in patients with pneumonia. Objective of this study was to identify the parameters of CURB-65 score that have higher association with mortality in patients with severe CAP. Material and methods. One hundred and two patients with community-acquired pneumonia were enrolled in the study. The study was conducted at the Intensive Care Department of the Clinic for Infectious Diseases and Febrile Conditions-Skopje. Demographic, clinical and biochemical parameters were analyzed and CURB-65 was calculated in each patient at admission. Predictors were identified using logistic regression analysis. Receiver Operating Characteristic Curve (ROC) was constructed for assessing discriminative power of analyzed parameters. Results. CURB-65 identified severe CAP in 32 (31,4%) patients, with overall mortality rate of 62,5%. Confusion, respiratory rate > 30/min and urea > 7mmol/L had significant association with the mortality. Conclusion. CURB-65 is a simple tool that can identify patients with severe CAP and can be used for early prediction of patients mortality.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Phisyological and biochemical factors in predicting outcome in severe community-acquired pneumonia
    (Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, 2008)
    ;
    ;
    The aim of our study was to identify physiologic and biochemical parameters of the patients on admission to hospital that will predict the death from severe community-acquired pneumonia. The study is a retrospective evaluation of patients with clinically and radiologically diagnosed community-acquired pneumonia, treated in the Intensive Care Unit of the Clinic for Infectious Diseases, Skopje, Macedonia in the period between 2003-2005. Eighty-one patients were included in the study, divided in two groups: group A - survivors and group B - non-survivors. Age, gender, symptoms before admission, co-morbidity, tobacco smoking, body temperature, heart rate, respiratory rate, arterial blood pressure, leukocytes count, haematocrit, glycemia, urea, sodium, serum albumen and arterial oxygen saturation were measured in each patient on admission. Results: Twenty-nine (35,8%) of all analyzed patients died, with mean age 63,1±17,9. From patients who died, 19 (43,2%) were males. Smoking, heart rate > 90/min, tachipnea ≥ 25/min., body temperature > 38, 5°C, leucocytes count > 10x10 9/L, uremia >7,4mmol/L and hypoxemia <90% were significantly associated with death on admission of patients with severe community-acquired pneumonia. In conclusion, severe community-acquired pneumonia is a serious life-threatening infection with high mortality. Identifying factors that predict adverse outcome on admission of the patients will contribute in undertaking appropriate treatment and management of this disease.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Evaluation of severity scoring systems in patients with severe community acquired pneumonia
    ("N Gh Lupu" Foundation of Internal Medicine and Romanian Academy, 2021-12)
    ;
    ;
    ;
    ;
    Background. The aim of this study was to evaluate the ability of severity scoring systems to predict 30-day mortality in patients with severe community-acquired pneumonia. Methods. The study included 98 patients aged ≥18 years with community acquired pneumonia hospitalized at the Intensive Care Unit of the University Clinic for Infectious Diseases in Skopje, Republic of North Macedonia, during a 3-year period. We recorded demographic, clinical and common biochemical parameters. Five severity scores were calculated at admission: CURB 65 (Confusion, Urea, Respiratory Rate, Blood pressure, Age ≥65 years), SCAP (Severe Community Acquired Pneumonia score), SAPS II (Simplified Acute Physiology Score), SOFA (Sequential Organ Failure Assessment Score) and MPM (Mortality Prediction Model). Primary outcome variable was 30-day in-hospital mortality. Results. The mean age of the patients was 59.08 ± 15.76 years, predominantly males (68%). The overall 30-day mortality was 52%. Charlson Comorbidity index was increased in non-survivors (3.72 ± 2.33) and was associated with the outcome. All severity indexes had higher values in patients who died, that showed statistical significance between the analysed groups. The areas under curve (AUC) values of the five scores for 30-day mortality were 0.670, 0.732, 0,726, 0.785 and 0.777, respectively. Conclusion. Widely used severity scores accurately detected patients with pneumonia that had increased risk for poor outcome, but none of them individually demonstrated any advantage over the others.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    FATAL ACUTE SELF-POISONING WITH ONE PHOSTOXIN TABLET – A CASE REPORT
    (2023-05)
    ;
    Niko Bekarovski
    ;
    Andon Chibishev
    ;
    ;
    Aluminum phosphide (AlP) is well known as an effective pesticide for grain preservation, but also as a suicidal agent due to its high human toxicity. Phosphine gas (PH3), which is released in contact with stomach acid, is responsible for systemic toxicity and high mortality. We report the first case of severe intentional AlP poisoning treated in our clinic with a fatal outcome and review the therapeutic modalities. A 35-year-old woman with a history of epilepsy was admitted to the University Clinic for Toxicology two hours after the intentional ingestion of a phostoxin (AlP) tablet. She presented with vomiting, abdominal pain, leukocytosis, ECG changes (prolonged PT interval, inverted T waves in D3, AVF, and left precordial leads), hypotension (80/40 mmHg, heart rate 120/min) and respiratory failure, after which she was transferred to the ICU. Signs of hepatic lesion, rhabdomyolysis, renal failure and metabolic acidosis (pO2 9.6 kPa, pCO2 4.14 kPa, pH 7.15, bicarbonate 11 mmol/L, BE -15) were noted. Despite the application of mechanical ventilation, fluid supplementation and inotropic support, hemodynamic instability worsened. Cardiopulmonary resuscitation was performed three times, but unfortunately the patient had a fatal outcome on the fourth day of hospitalization. Freshly opened phostoxin tablets (3 g) are very toxic, and the dose of AlP they contain is sufficient to cause progressive life-threatening symptoms and a fatal outcome. In the absence of antidote, consensus on treatment and elucidated mechanisms of toxicity, the key to treatment is rapid decontamination and initiation of resuscitation measures.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Clinical Characteristics, risk factors and outcome in patients with in tracerebral haemorrhage
    (Leage against epilepsy of Macedonia, 2015)
    ;
    ;
    Mitrevska Velkova Jasmina
    ;
    Babunovska Marija
    ;
    AbstractIntracerebral haemorrhage is a meaningful factors in the neurological praxis, as an urgent condition that requires timely detection and treatment with the purpose of improving trhe outcome. the aim of the study is to examine the clinical characteristics, risk factors and the outcome in patients with intacerebral haemorrhage. At the Department of urgent neurology of the University clinic of neurology in Skopje, Macedonia, a retrospective study was performed, with which 177 patients with intracerebralk heamorrhage, hospitalized at th University clinic of neurology within a two year period, are encompassed. the Main characteristics of the clinical features, risk factors, intrahospital complications and patient outcome werw researched. The results point to a nesessity of increased control of the risk factors with the patients, the effect of witch would be subject to futher studies.